ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

U.S. funded treatments in the country have helped reduce deaths from HIV/AIDS to around 14,000 a year, from as high as 200,000.

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Ending USAID could lead to the deaths of 14 million people over the next five years, an analysis from a medical journal ...

In the brightly lit corridors of a Nigerian hospital, an unspoken fear lingers, not just among patients, but among the very hands trained to heal them. In spite of decades of awareness campaigns, ...

As Uganda grapples with a resurgence of new HIV infections, we must confront the uncomfortable truth: complacency is our greatest enemy. According to an Economic Policy Research Centre ( EPRC) report ...

The emergency kits include medication to prevent HIV and other sexually transmitted infections, as well as unwanted pregnancies.

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for ...

In the wake of U.S. aid cuts, Pastor Billy is reminded of his twin sister's death from AIDS. He doesn't want 9-year-old Diana, who's HIV-positive, to meet the same fate.

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday.

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Breeze, a Louisville nonprofit that supports LGBTQ+ young adults, paused its free HIV testing services due to federal funding ...